Inogen price target raised to $190 from $145 at Piper Jaffray. Piper Jaffray analyst JP McKim raised his price target on Inogen to $190 after the company’s Q1 earnings beat and raised FY18 revenue guidance after market close today. The analyst notes that most of the beat came from the BTB segment, though DTC and international business units were also “strong”. McKim is particularly impressed with the company’s 77% volume growth, adding that while the stock trades at a high multiple, its accelerating growth and low market penetration justify the Overweight rating.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.